TAVR in cancer; healing the sickest of the sick
- PMID: 33460266
- DOI: 10.1002/ccd.29445
TAVR in cancer; healing the sickest of the sick
Comment on
-
Transcatheter aortic valve replacement in patients with a history of cancer: Periprocedural and long-term outcomes.Catheter Cardiovasc Interv. 2021 Jan 1;97(1):157-164. doi: 10.1002/ccd.28969. Epub 2020 Jun 4. Catheter Cardiovasc Interv. 2021. PMID: 32497385
References
REFERENCES
-
- Balanescu SM, Balanescu DV, Donisan T, et al. The Onco-cardiologist dilemma: to implant, to defer, or to avoid Transcatheter aortic valve replacement in cancer patients with aortic stenosis? Curr Cardiol Rep. 2019;21(8):83. https://doi.org/10.1007/s11886-019-1166-0.
-
- Schechter M, Balanescu DV, Donisan T, et al. An update on the management and outcomes of cancer patients with severe aortic stenosis. Catheter Cardiovasc Interv. 2019;94(3):438-445. https://doi.org/10.1002/ccd.28052.
-
- Iliescu CA, Grines CL, Herrmann J, et al. SCAI expert consensus statement: evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of India, and sociedad Latino Americana de Cardiologia intervencionista). Catheter Cardiovasc Interv. 2016;87(5):E202-23. https://doi.org/10.1002/ccd.26379.
-
- Brouwer J, Nijenhuis VJ, Delewi R, et al. Aspirin with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med. 2020;383(15):1447-1457. https://doi.org/10.1056/NEJMoa2017815.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical